Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It

Waves in a room

The International Journal of Molecular Sciences 

Abstract

Since 2009, we built up a database which presently includes more than 2000 electrohypersensitivity (EHS) and/or multiple chemical sensitivity (MCS) self-reported cases. This database shows that EHS is associated in 30% of the cases with MCS, and that MCS precedes the occurrence of EHS in 37% of these EHS/MCS-associated cases. EHS and MCS can be characterized clinically by a similar symptomatic picture, and biologically by low-grade inflammation and an autoimmune response involving autoantibodies against O-myelin. Moreover, 80% of the patients with EHS present with one, two, or three detectable oxidative stress biomarkers in their peripheral blood, meaning that overall these patients present with a true objective somatic disorder. Moreover, by using ultrasonic cerebral tomosphygmography and transcranial Doppler ultrasonography, we showed that cases have a defect in the middle cerebral artery hemodynamics, and we localized a tissue pulsometric index deficiency in the capsulo-thalamic area of the temporal lobes, suggesting the involvement of the limbic system and the thalamus. Altogether, these data strongly suggest that EHS is a neurologic pathological disorder which can be diagnosed, treated, and prevented. Because EHS is becoming a new insidious worldwide plague involving millions of people, we ask the World Health Organization (WHO) to include EHS as a neurologic disorder in the international classification of diseases.

Keywords: electrohypersensibility, multiple chemical sensitivity, neurologic disease, oxidative stress, melatonin, O-myelin, inflammation, histamine, radiofrequency, extremely low frequency, electromagnetic fields

1. Introduction

The term electromagnetic hypersensitivity or electrohypersensitivity (EHS) was first proposed in 1991 by William Rea to identify the clinical condition of patients reporting health effects while being exposed to an electromagnetic field (EMF) []. This term was then used in 1997 in a report provided by a European group of experts for the European Commission to clinically describe this unusual pathology, which may imply EMF exposure [].

In 2002, Santini et al. in France reported similar symptomatic intolerance in users of digital cellular phones and among people living near wireless communication base stations [,]. In 2004, because of the seemingly worldwide prevalence increase in EHS, the World Health Organization (WHO) organized an international scientific workshop in Prague to define and characterize EHS. Although not acknowledging EHS as being caused by EMF exposure, the Prague working group clearly defined EHS as “a phenomenon where individuals experience adverse health effects while using or being in the vicinity of devices emanating electric, magnetic, or electromagnetic fields” []. WHO then acknowledged EHS as an adverse health condition []. However, according to a previous 1996 International Program on Chemical Safety (IPCS)-sponsored conference in Berlin on multiple chemical sensibility (MCS) [], it was recommended to qualify such unknown new pathological conditions under the term of “idiopathic environmental intolerance (IEI)”. Thus, following the Prague workshop, instead of using the term EHS, it was proposed to use the term “idiopathic environmental intolerance attributed to EMF (IEI-EMF)” to name this particular pathological condition, because of the lack of a proven causal link between EHS and EMF exposure, and no proven physiopathological mechanism linking EMF exposure with clinical symptoms.

That is indeed what WHO officially stated in its 2005 fact sheet 296 [], indicating that “EHS resembles MCS, another disorder associated with low-level environmental exposure to chemicals …” and that because of “non-specific symptoms” and “no clear diagnostic criteria”, this “disabling condition” could not be diagnosed medically. In addition, in 2002 and 2013, WHO classified extremely low frequencies (ELF) and radiofrequencies (RF) respectively as possibly carcinogenic (group IIB), meaning that EMFs may cause cancer. This past scientific evolution is summarized in Table 1.

This is such a thorough article so I strongly encourage you to click on this link and go to the original source as it may lead you to other answers/inquiries from what you see on the sidelines of their site.  There’s always a summary at the end of these published studies/reviews if you don’t want to read the entire article: 

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139347/?fbclid=IwAR3lkIYPOqYiWyvEQWdzjzmk9NzEqDoqnVF9A-svwLi7R8HmnbHqUGg3s8I

One thought on “Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s